The Arctic Innovation Ecosystem is the operational entity of the HNDG development portfolio, dedicated to driving growth in the Arctic region through real-estate development, services, and programs. With a focus on increasing talent density and fostering innovation, the Arctic Innovation Ecosystem has three main operations: 1. Developing the leading Arctic Innovation & Student campus, including universities, coworking, and innovation spaces 2. Creating innovation programs within the ArcTech industries (Built Environment, Energy, Food Tech, Health Tech, Maritime & Logistics, and Tourism & Hospitality) 3. Facilitating the leading Arctic Innovation network

We're here to help your restaurant achieve online success Our mission is simple. We're here to help restaurants grow sustainably. Restaurants have become lifestyle brands. With forward-thinking digital products, restaurateurs will create the same perfect experience online as they already do offline, resulting in a more valuable and sustainable business.

Apiir is a software company that is solving issues in the bicycle industry by providing innovative solutions for bike fitting and selection. Using new image analysis technology, we have developed a bike fitting solution that is easy and effective for bike retailers to use in-store. Our solution helps cyclists get a perfect fit by analyzing their body measurements and bike geometry. Additionally, we have created an API that allows third-party apps to integrate our bike size solution into their platforms. Our mission is to make bike fitting and selection more accessible, efficient, and enjoyable for everyone in the cycling industry.

Denominator is the leading provider of human-centric data & insights on companies and countries globally Denominator covers more than 3.5 million public and private companies across 195+ countries and 85+ industries. With raw data on Board, Executive, and the Company level, across 15+ diversity, human rights, and health & safety the dataset is the most granular and comprehensive of its kind, driving detailed scores & rating models to measure social performance across boarders & industries. Visit www.denominator.com for more information.

OrbisCure - A tool for organizations to detect and remedy stress in time. Stress can be extremely difficult to detect and remedy before it develops into sick days or sick leave. Lack of insights makes it difficult to act in time. Fortunately, you can combat stress when you detect it and provide preventive support. OrbisCure is an app-based solution that provides your employees with monthly stress measurements, on-demand psychology sessions, and tailored eLearning courses. Our Harvard & Stanford University endorsed learning method ensures that complex knowledge collected among +20 of leading Scandinavian psychologists and doctors is transformed into practical and applicable knowledge.

We’re an ambitious scale-up SaaS company listed on Nasdaq First North in Copenhagen, providing an easy-to-use compliance management platform for larger organizations. In essence, we are here to increase trust and transparency through enabling solid processes for tax and finance compliance as well as to an increasing degree in the ESG arena. With increasing regulations, the need to provide content-based solutions is rising. With Impero organizations can improve and automate the way they manage risk and compliance. We are dedicated to making it easier for companies to deliver what they promise. We build trust based on actions, not on words. This is how we secure trust and transparency for a better tomorrow. Impero continues our ambitious growth strategy and has managed to deliver a compounded annual growth rate well above 40% over the past five years, with a set ambition to continue high-paced growth going forward. Your contribution is essential to accelerating our growth. Our customer base comprises more than 150 companies headquartered in 10 countries, with users in +80 countries, including many large, blue-chip customers such as Volkswagen Group, Siemens AG, Mærsk and many more. Impero serves approx. 25% of the OMX C25 companies in Denmark and 10 of the Company’s customers are Fortune2000 companies. In addition, Impero has proven applicable in both private and public organizations, domestically and internationally. We are Impero. Come join us!

Dreamwork er et rekrutterings- og bemanningsbyrå med kommersielle og kommersielle stillinger som spesialfelt. Vi er godkjent av NHO Service og Handel, hvilket betyr at Dreamwork har dokumentert kvalitet og ryddighet i alle våre rekrutterings- og bemanningsrutiner. Dreamwork er et rekrutterings- og bemanningsbyrå, som er godkjent av NHO Service og Handel. Spesialisert innen kommersielle og finansielle stillinger. Det viktigste for oss i Dreamwork er at du som arbeidsgiver finner drømmekandidaten, og at du som arbeidssøker finner drømmejobben. Det er dette som er selve drivkraften i alt vi gjør, og som inspirerer oss til å tenke nytt og kreativt på rekrutterings- og bemanningsprosessen. Vi er et rekrutteringsbyrå som satser stort på ny teknologi og digitale kanaler for å finne de beste kandidatene, og tar i bruk flere ulike rekrutteringsverktøy og prosesser – som blant annet: Dreamwork Assessment, som består av personlighetsanalyser og evnetester for å matche kandidater og arbeidsgivere på best mulig måte. Proaktivt søk og fortløpende kandidatintervjuer, noe som betyr at vi kanskje allerede har kandidaten du ser etter. Digital markedsføring, sosiale medier og Dreamwork Tech, slik at vi finner de beste kandidatene – og tiltrekker oss de som i utgangspunktet ikke var på jobbjakt.

Drifti is a b2b saas that aims to give back control to the people who work at all levels in the construction industry. Drifti does this by centralizing all administration to one place and by working for you, not by you. That means more productivity in all parts of the value chain. Drifti is growing quickly in Norway where we now work mainly with plumbers and other craftspeople. We are looking to grow our service and team in Oslo, Norway.

Med-Storm's Skin Conductance Algesimeter (SCA) uses the principle of skin conductance to measure pain, allowing us to titrate the right amount of pain medication for each, individual patient. This award-winning technology is not affected by changes in blood circulation, heart rate, hypotensia, environmental temperatures, and hypoxia, and shows low variation between individuals at the same level of pain. The pain monitor can be used on patients as young as 23 weeks of gestational age, as well as geriatric patients. MS is currently working on a miniaturized and wireless version of the SCA.

Disruptive Engineering enables more effective planning, management, and monitoring of road networks. Proprietary sensor hardware 'made in Norway'Use AI and neural networks for detailed classification of vehicles. Privacy-by-design solution ensuring that no personal data is stored or shared. With traffic expected to grow by 60% by 2050, and with congestion and safety already being an issue, there is a pressing need to utilize road networks more efficiently. Both Statens Vegvesen and Nye Veier see our first sensor VS1, and the valuable data it provides, as a potential solution to achieve this as well as an opportunity to digitalize roads and infrastructure for the forthcoming Intelligent Transportation Systems (ITS) that are being implemented across Europe.Statens Vegvesen linkNye Veier link

Rada Labs are bringing app ideas to life. With a big focus on creativity and innovation the company develop never seen before applications for smartphones, tablets, smart watches and computers. Rada Labs consists of creative people who love to develop high quality products and services. With innovation in focus, we develop our own brands within apps as well as develop applications for our customers. We build apps for smartphones, smartwatches, tablets and computers. By using tailored innovation processes and the latest technology in cloud services, machine learning and artificial intelligence, we can create smart applications that reach all target groups!

Monio AS (org. nr. 913 978 617) er et heleid datterselskap av SpareBank 1 SR-Bank ASA (org. nr. 937 895 321). Monio AS formidler lån til små og mellomstore bedrifter og er regulert av Finanstilsynet med tillatelse til å drive virksomhet som betalingsforetak og er registrert som låneformidler. Som lånformidler er Monio ikke en part i låneavtalen mellom långiver og låntaker.

OncoImmunity is a bioinformatics company providing unique machine-learning software to identify tumor-specific mutations that can be targeted by a patient’s own immune system (known as neoantigens). The OncoImmunity solution is important because recent breakthroughs in the field of Immuno-Oncology (I-O) such as the development of checkpoint inhibitors and personalized cancer vaccines, clearly demonstrate that a patient’s immune system can be harnessed to successfully treat cancer. The cost of identifying tumor-specific mutations in a patient’s cancer using next-generation sequencing (NGS) is now trivial and this technology will be key to enabling truly personalized immunotherapies to be developed in a technically and economically feasible manner. However, the remaining challenge that currently limits the field, and which is addressed by the OncoImmunity solution, is predicting which tumor-specific mutations can stimulate a patient’s immune system i.e. are immunogenic. Using NGS data as input, the OncoImmunity software enables accurate patient selection for cancer immunotherapy and can identify optimal targets for personalized cancer vaccines & cell therapies in a clinically actionable time frame. Beginning from this first product offering, OncoImmunity has the vision to become the world’s leading provider of software to guide cancer immunotherapy to improve survival rates for cancer patients. To achieve this OncoImmunity has assembled a growing team of world-class bioinformaticians, data scientists, and software engineers; developing its cutting-edge machine-learning technology that will help fulfill the promise of immunotherapy in the fight against cancer. OncoImmunity’s technology will disrupt the I-O field by offering regulatory-compliant prediction software on a software-as-a-service basis (SaaS). This will allow big pharma, biotechnology, and immunotherapy companies of any size to access OncoImmunity’s cutting-edge prediction software. The company is headquartered in an ideal scientific and entrepreneurial ecosystem to develop its technology at the Oslo Cancer Cluster Incubator; adjacent to the Institute for Cancer Research and the Norwegian Radium Hospital. OncoImmunity is a privately held company, founded in 2014 by experienced bioinformatics scientists (Dr. Trevor Clancy and Professor Eivind Hovig), and an experienced immunologist with a business development background (Dr. Richard Stratford). The company is backed by private financing from the Norwegian Radium Hospital Research Foundation, the Norwegian Cancer Society, STARTUPLAB, and Grotmol Solutions, in addition to a number of private software investors. The company is also supported by grants awarded from the Norwegian Research Council, Innovation Norway, and the EU. The company has already established both national and international collaborations and pilot projects to develop further proof-of-concept data and validate its software.

RESPINOR is a privately-owned medical device company, founded in Oslo, 2015. We have developed an objective measure of breathing for critically ill patients within intensive care. The technology provides precise, continuous and real-time information of diaphragm function, our main breathing muscle, to increase the quality of care and reducing costs. RESPINOR’s technology is the winner of Horizon 2020 both in phase I and II. We are addressing an unmet medical need because every breath counts.

A bio-and medtech Company developing and selling proprietary solutions for using oxygen in various applications. Currently focussing on beverages (water, sports- and isotonic drinks), wound healing, cosmetics and fish farming. Licensing platform technology for applying oxygent to other products. Oxy Solutions is a privately held Norwegian based biotech company that has developed and patented an innovative technology for highly oxygenating liquid. Oxy Solutions'​ core business and strategy is to develop, document, IP protect, and commercialize the technology primarily within wound healing. The company has an in-house R&D facility in Norway. The company has funding from the Norwegian Research Council. Oxy Solutions is in possession of patented technology that makes it possible to greatly increase the dissolved level of oxygen in water. Tests have indicated stable levels in excess of 70 mg/l, or approximately 10 times higher than previously thought possible.